Top Markets
Coin of the day
Egetis Therapeutics AB (publ) Egetis Therapeutics AB (publ)

Egetis Therapeutics AB (publ)

EGTX
Rang în acțiuni #14551
Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to... Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to progressing drug development, primarily focusing on late-stage projects. The company's core mission involves addressing significant unmet medical needs within the orphan drug sector, concentrating on severe and rare or niche diseases. Its current therapeutic pipeline includes two key drugs undergoing Phase IIb/III clinical trials: Aladote, which is designed to mitigate the risk of acute liver damage associated with acetaminophen/paracetamol poisoning, and Emcitate, intended for the management of MCT8 deficiency, a rare congenital disorder impacting thyroid hormone signaling. Established in 2006, Egetis Therapeutics AB (publ) is headquartered in Stockholm, Sweden, and was previously known as PledPharma AB (publ) until its name change in December 2020.
Preț acțiune
$0.87679425
Ultima sincronizare: 2026-08-31
Capitalizare de piață
$407.66M
Schimbare (1 zi)
-1.88%
Schimbare (1 an)
58.03%
Țară
SE
Tranzacționează Egetis Therapeutics AB (publ) (EGTX)

Categorie

Istoric al prețului acțiunii pentru Egetis Therapeutics AB (publ) (EGTX)
Cel mai mare preț de închidere: $0.82 pe 2026-08-01

Cel mai mic preț de închidere: $2.05 pe 2011-04-01
Istoric al prețului acțiunii pentru Egetis Therapeutics AB (publ) din 2011 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 16.80%
2025 -9.69%
2024 12.61%
2023 5.26%
2022 -32.21%
2021 -1.08%
2020 -64.01%
2019 24.17%
2018 -26.69%
2017 31.53%
2016 -66.48%
2015 78.45%
2014 56.36%
2013 68.37%
2012 3.47%
2011 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.37 -11.93%
AU
$138.80 476.17%
US
$749.90 5.10%
CH